GNH USA

Europe — EMA

Ondansetron Crescent Pharma (Ondansetron Hydrochloride Dihydrate)

Ondondansetron, the active ingredient in Ondansetron Crescent Pharma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use.

Request sourcing

1
Pack/s

What is Ondansetron Hydrochloride Dihydrate?

Ondondansetron, the active ingredient in Ondansetron Crescent Pharma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron Hydrochloride Dihydrate used for?

Ondansetron is a selective 5‑HT3 receptor antagonist that  …  …  ...  … …  …  …  … …  …  …

-  Chemotherapy‑      …  … …  … … …  …  ...  …  ...  ...  … 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ondansetron Hydrochloride Dihydrate
Route
Oral Use
Manufacturer
Crescent Pharma Limited
Origin
EU

Related products